Cannabis Company Avana Canada Inc. Changes Name to Mera Cannabis Corp.

Mera Cannabis Corp. launches rebrand in light of expansion domestically and abroad

TORONTO, June 6, 2019

Mera Cannabis Corp. (“Mera” or the “Company“), formerly Avana Canada Inc., has filed articles of amendment under the Canada Business Corporations Act to change its corporate name from Avana Canada Inc. to Mera Cannabis Corp., effective May 24, 2019. The change of name is part of a larger rebranding initiative to better represent Mera’s products and services.

Mera is a family of cannabis brands and businesses positioned for growth domestically and abroad. As a licensed producer under the Cannabis Act (Canada), the Company’s efforts are focused on medical cannabis product innovation, leveraging an exclusive partnership with Covar Pharmaceuticals Inc. Mera has an EU GMP-built cultivation and processing facility in St. Thomas, Ontario and it has submitted applications with Health Canada for additional licensed facilities in St. Thomas (processing) and Kingsville, Ontario (cultivation), which would give the Company the ability to expand its cultivation and processing footprints by up to 1.2 million sq. ft. and 88,000 sq. ft., respectively.

“Our rebrand to Mera symbolizes a significant step forward for our business. The Avana name was originally established with the intent of representing a premium line of cannabis products. With the growth of our business, we needed an identity that could represent much more than just a product,” says Zubin Jasavala, Chief Executive Officer of Mera. “Mera, which is suggestive of “mother” in many languages, is more than just a memorable name; it represents the heart of our cannabis businesses.”

The “Avana” mark and brand is being used in connection with the Company’s premium line of dried cannabis flowers, intended to launch in the Canadian market later this year.

About Mera Cannabis Corp.

Mera is focused on producing consumer-driven, high-value cannabis products at its EU GMP-built cultivation and processing facility in St Thomas, Ontario. It has two additional facilities currently under Health Canada licensing review in St. Thomas (processing) and Kingsville, Ontario (up to 1.2M sq. ft. of greenhouse cultivation), where the Company’s efforts are focused on medical cannabis product innovation. Additionally, Mera’s family of cannabis brands and businesses include CannaWay Clinic, a national network of clinics specializing in cannabis treatment programs, and Garden Variety, a chain of cannabis retail stores in Manitoba operated through a joint-venture partnership.  Mera has also signed a letter of intent with the Maltese economic development agency, Malta Enterprise, to initiate the development of a medical cannabis production facility in Malta as a primary entry point into European medical cannabis markets. For more information about Mera, please visit meracannabis.com.

FOR MORE INFORMATION PLEASE CONTACT:

Emily Ondercin-Bourne
emily.ondercin-bourne@meracannabis.com

 CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, Mera’s future plans with respect to cannabis sales and processing and Mera’s intention to expand internationally. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political, contractual and social uncertainties; and the delay or failure to receive regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Mera assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.